Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Glycoprotein IIb/IIIa inhibitors and acute coronary syndromes: summary report of the full submission to NICE, and beyond.

× No keyword cloud information.

15 in total

1. Perivalvular abscesses in infective endocarditis.

Authors: C M Oakley
Journal: Eur Heart J Date: 1999-02 Impact factor: 29.983

2. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.

Authors: E J Topol; J J Ferguson; H F Weisman; J E Tcheng; S G Ellis; N S Kleiman; R J Ivanhoe; A L Wang; D P Miller; K M Anderson; R M Califf
Journal: JAMA Date: 1997-08-13 Impact factor: 56.272

Review 3. Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence.

Authors: E J Topol
Journal: Circulation Date: 1998-01-20 Impact factor: 29.690

4. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial.

Authors: J A de Lemos; E M Antman; C M Gibson; C H McCabe; R P Giugliano; S A Murphy; S A Coulter; K Anderson; J Scherer; M J Frey; R Van Der Wieken; F Van De Werf; E Braunwald
Journal: Circulation Date: 2000-01-25 Impact factor: 29.690

Review 5. Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease.

Authors: D A Vorchheimer; J J Badimon; V Fuster
Journal: JAMA Date: 1999-04-21 Impact factor: 56.272

6. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management.

Authors: C Heeschen; C W Hamm; B Goldmann; A Deu; L Langenbrink; H D White
Journal: Lancet Date: 1999-11-20 Impact factor: 79.321

7. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.

Authors: E M Antman; R P Giugliano; C M Gibson; C H McCabe; P Coussement; N S Kleiman; A Vahanian; A A Adgey; I Menown; H J Rupprecht; R Van der Wieken; J Ducas; J Scherer; K Anderson; F Van de Werf; E Braunwald
Journal: Circulation Date: 1999-06-01 Impact factor: 29.690

8. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.

Authors: B S Coller; E I Peerschke; L E Scudder; C A Sullivan
Journal: J Clin Invest Date: 1983-07 Impact factor: 14.808

9. Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.

Authors: A S Go; E M Hylek; K A Phillips; L H Borowsky; L E Henault; Y Chang; J V Selby; D E Singer
Journal: Circulation Date: 2000-07-04 Impact factor: 29.690

10. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

Authors: S J Brener; L A Barr; J E Burchenal; S Katz; B S George; A A Jones; E D Cohen; P C Gainey; H J White; H B Cheek; J W Moses; D J Moliterno; M B Effron; E J Topol
Journal: Circulation Date: 1998-08-25 Impact factor: 29.690

1 in total

Review 1. Gene therapy for coronary restenosis: is the enthusiasm justified?

Authors: M O'Sullivan; M R Bennett
Journal: Heart Date: 2001-11 Impact factor: 5.994

1 in total